Seattle, WA, United States of America

Cyr De Imus

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 20.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Cyr De Imus: Pioneering CAR Technology in Seattle

Introduction

Cyr De Imus, an innovative inventor based in Seattle, WA, has made significant contributions to the field of immunotherapy through his groundbreaking work on chimeric antigen receptors (CARs). With one patent to his name, he has paved the way for advancements in cancer treatment by focusing on specific targets such as B-cell maturation antigen (BCMA).

Latest Patents

De Imus's notable patent is titled "Chimeric Antigen Receptors Specific for B-Cell Maturation Antigen and Encoding Polynucleotides." This patent includes chimeric receptors comprising BCMA-binding molecules, such as anti-BCMA antibodies. The invention outlines the genetic engineering of cells expressing the CARs, enabling them to bind specifically to BCMA. This technology has potential applications in adoptive cell therapy, marking a significant step forward in cancer treatment methodologies.

Career Highlights

Throughout his career, Cyr De Imus has worked with renowned organizations that focus on innovative biotechnological solutions. He has held positions at Juno Therapeutics GmbH and Memorial Sloan Kettering Cancer Center, contributing his expertise in developing cutting-edge therapies aimed at improving patient outcomes in oncology.

Collaborations

In his professional journey, De Imus has collaborated with esteemed colleagues, including Blythe D. Sather and Eric L. Smith. These partnerships have enriched his research endeavors and allowed for the cross-pollination of ideas within the biotechnology field.

Conclusion

Cyr De Imus stands out as a visionary inventor whose patent on chimeric antigen receptors offers hope for improved cancer therapies. His contributions, alongside his collaborations with esteemed professionals and organizations, underscore the importance of innovation in healthcare and the ongoing fight against cancer. As the field continues to evolve, inventors like De Imus are crucial to unlocking new possibilities for patient care and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…